Cardiologist. Chief, CCU and Teaching and Research Department at Favaloro Foundation. Buenos Aires, Argentina. Professor of Cardiology, Favaloro University
This consensus document from the ESC Working Group on Thrombosis provides practical advice regarding best practice for personalizing DAPT in patients with ACS undergoing PCI. https://t.co/TfGYQPEfkT
UFH-STEMI trial: In STEMI patients undergoing primary PCI, pretreatment with UFH 70-100 IU/kg at prehospital first medical contact improved infarct-related artery patency without increasing the risk of BARC types 3-5 bleeding. #ACC26 View slides here: https://t.co/aEoDpNUpiE
Early surgery in asymptomatic patients with very severe aortic stenosis led to a lower risk of a composite of operative mortality or death from cardiovascular causes at 10 years than conservative care. Full RECOVERY trial results: https://t.co/tLqC25ccCJ
REHEALTH AF: first prospective study of ablation vs no ablation in pts ≥80 w/ #AFib. Ablation improved functional & structural outcomes; prognostic benefit emerged after multivariable adjustment. https://t.co/mIVeymBqY4 #JACCCEP#epAblation
This state-of-the-art review outlines current evidence on the mechanisms, prevalence, clinical relevance, and management of TAVI thrombosis and highlights ongoing clinical trials investigating this condition. https://t.co/zmRnf6hjZo
Among patients with anterior myocardial infarction, adding low-dose rivaroxaban to dual antiplatelet therapy did not significantly reduce left ventricular thrombus formation at 1 month but increased minor bleeding.
https://t.co/lSxD7zhy3L